| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Nurix Therapeutics, Inc. (NRIX) have been net sellers, shedding 49,260 shares worth roughly $1.2M on balance. In the past 30 days, 0 insiders bought and 4 sold.
All 4 insiders who sold still hold shares after their sales.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 123.5K | $3.19M | -6,861 | |
| CFO | 47.5K | $1.23M | -2,834 | |
| Other | 15.3K | $395.9K | -3,957 | |
| Dir | 10.8K | $277.6K | -22,583 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 20, 2024 | Hans van Houte56 | Chief Financial Officer | Sell10b5-1 | 20,000 | $20.01 | $400,216.00 | -29.3% | +18.0% | -45.2% | |
| Jun 13, 2024 | Christine Ring75 | Chief Legal Officer | Sale+OE10b5-1 | 1,864 | $17.02 | $31,721.18 | -8.6% | +42.1% | -28.7% | |
| Jun 12, 2024 | Christine Ring75 | Chief Legal Officer | Sale+OE10b5-1 | 1,900 | $17.01 | $32,319.00 | -8.7% | +48.0% | -27.5% | |
| Jun 5, 2024 | Christine Ring75 | Chief Legal Officer | Sale+OE10b5-1 | 400 | $17.00 | $6,801.00 | -2.0% | +47.4% | -25.9% | |
| Jun 3, 2024 | Christine Ring75 | Chief Legal Officer | Sale+OE10b5-1 | 1,596 | $17.01 | $27,152.91 | -7.4% | +54.9% | -24.7% | |
| May 2, 2024 | Hans van Houte56 | Chief Financial Officer | Sell10b5-1 | 3,499 | $12.83 | $44,878.17 | -4.9% | +71.9% | -11.5% | |
| Apr 30, 2024 | Hans van Houte56 | Chief Financial Officer | Sale+OE | 1,387 | $12.04 | $16,702.53 | -1.9% | +76.8% | -4.1% | |
| Apr 30, 2024 | Gwenn Hansen70 | Chief Scientific Officer | Sale+OE | 2,007 | $12.04 | $24,168.70 | -4.8% | +76.8% | -4.1% | |
| Apr 30, 2024 | Christine Ring75 | Chief Legal Officer | Sale+OE | 1,513 | $12.04 | $18,219.85 | -7.1% | +76.8% | -4.1% | |
| Feb 16, 2024 | Hans van Houte56 | Chief Financial Officer | Sell10b5-1 | 6,812 | $10.02 | $68,222.86 | -9.1% | +56.0% | +78.2% |